Amantadine Extended-Release Tablets and Golimumab Subcutaneous
Determining the interaction of Amantadine Extended-Release Tablets and Golimumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: amantadine
Brand name: Gocovri, Osmolex ER, Symmetrel
Synonyms: Amantadine
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amantadine Extended-Release Tablets-GoLYTELY
- Amantadine Extended-Release Tablets-Gonadorelin
- Amantadine Extended-Release Tablets-Gonadorelin Intravenous, Injection
- Amantadine Extended-Release Tablets-Gonadotropin, Chorionic
- Amantadine Extended-Release Tablets-Gonal-F
- Amantadine Extended-Release Tablets-Gonal-f RFF
- Golimumab Subcutaneous-Amantadine Hydrochloride
- Golimumab Subcutaneous-Amantadine Oral Solution USP
- Golimumab Subcutaneous-Amantadine Syrup
- Golimumab Subcutaneous-Amantadine Tablets
- Golimumab Subcutaneous-Amaryl
- Golimumab Subcutaneous-Ambator Diclofenac Patch